Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Anastrozole/clomifene

Drug misuse in the form of drug doping leading to various toxicities: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rochoy M, et al. Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions. Therapies 77: 683-691, No. 6, Nov 2022. Available from: URL: https://www.journals.elsevier.com/therapies Rochoy M, et al. Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions. Therapies 77: 683-691, No. 6, Nov 2022. Available from: URL: https://​www.​journals.​elsevier.​com/​therapies
Metadaten
Titel
Anastrozole/clomifene
Drug misuse in the form of drug doping leading to various toxicities: 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41292-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Voriconazole

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Elasomeran